Aclaris Therapeutics Announces Notice of Allowance for Two U.S. Patent Applications Covering Baricitnib and Decernotinib, Respectively, for Hair Loss Disorders
Go back to Aclaris Therapeutics Announces Notice of Allowance for Two U.S. Patent Applications Covering Baricitnib and Decernotinib, Respectively, for Hair Loss Disorders| (NASDAQ: ACRS) | Delayed: 5.58 -0.13 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.71 | 52 Week High | $33.88 | |||
| Open | $5.76 | 52 Week Low | $14.12 | |||
| Day High | $5.76 | P/E | N/A | |||
| Day Low | $5.46 | EPS | $0.00 | |||
| Volume | 1,401,880 | |||||
